These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5442915)

  • 1. Trivalent oral poliovirus vaccine: a comparison of two infant immunization schedules.
    Hardy GE; Hopkins CC; Linnemann CC; Hatch MH; Witte JJ; Chambers JC
    Pediatrics; 1970 Mar; 45(3):444-8. PubMed ID: 5442915
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral poliomyelitis immunization. Comparison of the serological findings after two- and threefold application of a trivalent live vaccine].
    Kuwert E; Höher PG; Worringen W; Bohlmann HG; Thraenhart O
    Dtsch Med Wochenschr; 1970 Dec; 95(50):2505-9. PubMed ID: 5484755
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral vaccination against poliomyelitis using trivalent vaccines].
    Damjanowa M; Huber EG; Kraus P; Pötsch F
    Dtsch Med Wochenschr; 1970 Jun; 95(23):1265-8. PubMed ID: 4315949
    [No Abstract]   [Full Text] [Related]  

  • 4. Eradication of poliomyelitis in Cuba: a historical perspective.
    Más Lago P
    Bull World Health Organ; 1999; 77(8):681-7. PubMed ID: 10516790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of two schedules for administering trivalent oral poliovaccine].
    Hu XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1985 Sep; 19(5):275-7. PubMed ID: 3004841
    [No Abstract]   [Full Text] [Related]  

  • 6. [Poliomyelitis immunization].
    Vivell O
    Landarzt; 1967 May; 43(15):716-20. PubMed ID: 4305217
    [No Abstract]   [Full Text] [Related]  

  • 7. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Observation on immunizing effect of live trivalent oral poliomyelitis vaccine].
    Hu XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1982 Sep; 16(5):285-9. PubMed ID: 7151589
    [No Abstract]   [Full Text] [Related]  

  • 9. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of the poliomyelitis immunization campaign and syndromes associated with poliovirus in Singapore.
    Yin-Murphy M; Wong HB; Goh KT
    J Singapore Paediatr Soc; 1987; 29(3-4):99-107. PubMed ID: 2836655
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
    Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
    Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(30):829-30. PubMed ID: 19661857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Qualitative and quantitative immunological variations in children immunized with Sabin type live poliomyelitis vaccine by 2 immunization schedules].
    Topciu V; Gherman D; Plavoşin-Babuşceac L; Iutchin I; Ionesco C
    Arch Roum Pathol Exp Microbiol; 1966 Sep; 25(3):779-90. PubMed ID: 4292259
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
    Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing to injectable polio vaccine.
    Durham G
    N Z Med J; 1997 Oct; 110(1054):402. PubMed ID: 9397086
    [No Abstract]   [Full Text] [Related]  

  • 16. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Committee statement, American Academy of Pediatrics, Committee on Control of Infectious Diseases. Supplementary statement on oral poliovirus vaccines.
    J Med Assoc State Ala; 1966 Jan; 35(7):537-42. PubMed ID: 5902163
    [No Abstract]   [Full Text] [Related]  

  • 18. World wide experience with inactivated poliovirus vaccine.
    Bonnet MC; Dutta A
    Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trivalent oral polio vaccine: disappointing results.
    Ghosh S
    Pediatrics; 1971 Mar; 47(3):632-3. PubMed ID: 5547882
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oral immunization against poliomyelitis].
    Haas R
    Dtsch Med Wochenschr; 1973 Sep; 98(36):1682-3. PubMed ID: 4741244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.